Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1ACT-385781A (Actelion Epoprostenol)
(D00106)		[1] Epoprostenol[1] Epoprostenol (D00106) 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
2Current marketed FLOLAN (epoprostenol sodium)
(D00106)		[1] Epoprostenol[1] Epoprostenol (D00106) 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
3EPOPROSTENOL
(D00106)		[1] Epoprostenol[1] Epoprostenol (D00106) 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
4Epoprostenol for injection
(D00106)		[1] Epoprostenol[1] Epoprostenol (D00106) 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
5EPOPROSTENOL SODICO
(D00106)		[1] Epoprostenol[1] Epoprostenol (D00106) 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
6EPOPROSTENOL SODIUM
(D00106)		[1] Epoprostenol[1] Epoprostenol (D00106) 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
7Epoprostenol-Actelion
(D00106)		[1] Epoprostenol[1] Epoprostenol (D00106) 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
8New thermo stable formulation of epoprostenol sodium
(D00106)		[1] Epoprostenol[1] Epoprostenol (D00106) 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬